- Massive negative impact of COVID-19 on cancer screenings quantified in KU Medical Center faculty study published in JAMA Oncology
Apr 29, 2021 -- Nearly 10 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic, according to a study published in JAMA Oncology and researched by KU Medical Center faculty member Ronald Chen. Public attention to the problem is needed to prevent cancer deaths.
- Newly installed solar panels on two KU Medical Center buildings to lower electricity costs and support clean energy
Apr 21, 2021 -- To tap into more sustainable sources of power, two buildings on the University of Kansas Medical Center’s campus in Kansas City were recently crowned with a total of 306 solar panels. The energy they provide could save more than a quarter of a million dollars.
- Health Professions department renamed to reflect new athletic training program
Apr 15, 2021 -- The Department of Physical Therapy, Rehabilitation Science and Athletic Training, housed in the KU School of Health Professions, received approval recently from the Kansas Board of Regents to expand its name to fit its new degree offerings and its new mission.
- $4.2 million grant awarded for breast cancer chemoprevention study
Apr 09, 2021 -- Researchers at The University of Kansas Cancer Center have received a $4.2 million, five-year grant from the National Cancer Institute to study the effects of bazedoxifene and low-dose conjugated estrogen in women who are at increased risk for developing breast cancer and are experiencing menopausal symptoms.
- KU School of Medicine rises to No. 9 in U.S. News and World Report’s ranking of best medical schools for primary care
Mar 30, 2021 -- The University of Kansas School of Medicine now ranks in the top ten medical schools in the country for primary care, according to U.S. News and World Report’s rankings of medical schools in the United States for 2022, released on March 30
- 1937 KU nursing graduate remembered in ‘Ila’s War’
Mar 29, 2021 -- Ila Armsbury Herman, a 1937 graduate of the nursing program at the University of Kansas, shared with her niece the details of her time at KU and as an army nurse in World War II. The result was the book 'Ila's War.'
Categories: School of Nursing
- School of Medicine ‘class of change’ celebrates results of Match Day 2021
Mar 23, 2021 -- Medical students at the KU School of Medicine learned where they will be working after medical school in a yearly event called Match Day. The COVID-19 pandemic led to different ways to celebrate in 2021.
- KU Alzheimer’s Disease Center using $4.3 million NIH grant to power its research and dementia care efforts
Mar 18, 2021 -- With the three-year, $4.3 million award, the KU ADC will enhance care for people with dementia, improve its ability to recruit research volunteers and help the city and state become more dementia capable.
- New COVID-19 outpatient treatments including pill, injection and inhaled medicine part of clinical trial at KU Medical Center
Feb 11, 2021 -- Three new outpatient treatments will be tested at the University of Kansas Medical Center in efforts to broaden options for COVID-19 patients. These new treatments may make it easier to receive COVID-19 treatment outside a hospital, as they include an oral pill, an injection and a medication that can be inhaled through a home nebulizer.
- KU Medical Center professor seeks to promote equity in residency applications and virtual interviews
Feb 01, 2021 -- Kimberly J. Templeton, M.D., professor of orthopedic surgery at the University of Kansas Medical Center, led efforts to help women medical students maintain equity in the residency selection process.
- School of Medicine honors teaching excellence with virtual A Grand Affair
Jan 22, 2021 -- A Grand Affair on Jan. 15 recognized teaching excellence in the University of Kansas School of Medicine through a virtual ceremony.
Categories: School of Medicine
- Two new monoclonal antibody outpatient treatments for COVID-19 target older people and those with additional medical conditions
Jan 12, 2021 -- Two new monoclonal antibody treatments for outpatients with COVID-19 are being tested at the University of Kansas Medical Center. Known as BRII 196 and 198 and produced by Brii Biosciences, these investigational treatments are both monoclonal antibodies designed to block the ACE receptor.
Last modified: Jul 26, 2018